Literature DB >> 33509219

[18F]FDG Positron emission tomography with whole body magnetic resonance imaging ([18F]FDG-PET/MRI) as a diagnosis tool in Schwannomatosis.

I Gallais Sérézal1,2, S Ferkal3, L Lerman4, S Mulé5, B Funalot2, P Wolkenstein6,7.   

Abstract

Schwannomatosis is a rare autosomal dominant genetic syndrome characterized by the presence of multiple schwannomas. The main symptom is neurogenic pain. The diagnosis requires the presence of several schwannomas and whole-body [18F]FDG-PET/MRI might help detect extra schwannomas in patients when the diagnosis is uncertain. Among the 25 patients treated for Schwannomatosis in our tertiary center, three men and two women had had a [18F]FDG-PET/MRI performed, and the number of schwannomas detected by [18F]FDG-PET/MRI outnumbered the number of schwannomas suspected during the clinical examination. The majority of schwannomas exhibited a radiolabeling (median of 66.7%, range 28-93%). Our findings show that [18F]FDG-PET/MRI could prove useful when suspecting schwannomatosis to accelerate diagnosis and offer optimal care to patients.

Entities:  

Keywords:  Diagnosis; MRI; Schwannomatosis; [18F]FDG-PET

Mesh:

Substances:

Year:  2021        PMID: 33509219      PMCID: PMC7842033          DOI: 10.1186/s13023-021-01680-0

Source DB:  PubMed          Journal:  Orphanet J Rare Dis        ISSN: 1750-1172            Impact factor:   4.123


  9 in total

1.  Whole-body imaging in schwannomatosis.

Authors:  Avneesh Chhabra; Jaishri Blakely
Journal:  Neurology       Date:  2011-06-07       Impact factor: 9.910

2.  Retroperitoneal schwannoma misdiagnosed as an ovarian malignancy.

Authors:  Dong Hyu Cho
Journal:  BMJ Case Rep       Date:  2018-08-08

3.  FDG PET/CT of Intercostal Schwannoma.

Authors:  Si-Yun Wang; Dong-Lan Luo; Gang Chen; En-Tao Liu; Shu-Xia Wang
Journal:  Clin Nucl Med       Date:  2016-06       Impact factor: 7.794

4.  Utility of positron emission tomography in schwannomatosis.

Authors:  Bryan Lieber; ByoungJun Han; Jeffrey Allen; Girish Fatterpekar; Nitin Agarwal; Noojan Kazemi; David Zagzag
Journal:  J Clin Neurosci       Date:  2016-03-05       Impact factor: 1.961

5.  Schwannomatosis: a clinical entity distinct from neurofibromatosis type 2.

Authors:  P Wolkenstein; H Benchikhi; J Zeller; J Wechsler; J Revuz
Journal:  Dermatology       Date:  1997       Impact factor: 5.366

6.  Schwannomatosis/neurofibromatosis type 2 associated multiple schwannomas visualized on FDG-PET/CT.

Authors:  V Beylergil; S Haque; A Carver; M H Bilsky; J A Carrasquillo
Journal:  Rev Esp Med Nucl Imagen Mol       Date:  2013-04-11       Impact factor: 1.359

7.  Clinical features of schwannomatosis: a retrospective analysis of 87 patients.

Authors:  Vanessa L Merker; Sonia Esparza; Miriam J Smith; Anat Stemmer-Rachamimov; Scott R Plotkin
Journal:  Oncologist       Date:  2012-08-27

8.  MRI in acoustic neuroma: a review of 35 patients.

Authors:  W L Curati; M Graif; D P Kingsley; T King; C L Scholtz; R E Steiner
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

9.  Multiparametric whole-body anatomic, functional, and metabolic imaging characteristics of peripheral lesions in patients with schwannomatosis.

Authors:  Shivani Ahlawat; Asad Baig; Jaishri O Blakeley; Michael A Jacobs; Laura M Fayad
Journal:  J Magn Reson Imaging       Date:  2016-03-17       Impact factor: 5.119

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.